- I think that NUS's underlying business remains strong, despite the ongoing pandemic and economic recession.
- Moreover, I also think it's essential to address the company's regulatory risks, which I deem minimal due to its organic demand.
- Ultimately, I consider NUS an FCF machine that should continue to deliver consistent results over the long term.
- Unfortunately, my valuation model suggests that the shares are, at best, fairly valued. I estimate its fair value per share is $46.60.
- This is why I consider NUS a "hold" for now.
For further details see:
Nu Skin Enterprises: A Compelling MLM, But A Hold For Now